about
Central iliac arteriovenous anastomosis for hypertension: targeting mechanical aspects of the circulationGenetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunctionNovel paradigms for dialysis vascular access: downstream vascular biology--is there a final common pathway?Standardized definitions for hemodialysis vascular accessAberrant soluble epoxide hydrolase and oxylipin levels in a porcine arteriovenous graft stenosis modelA high red blood cell distribution width predicts failure of arteriovenous fistulaPredicting Early Death Among Elderly Dialysis Patients: Development and Validation of a Risk Score to Assist Shared Decision Making for Dialysis Initiation.Single nucleotide variants in the protein C pathway and mortality in dialysis patientsComprehensive and personalized care of the hemodialysis patient in tassin, france: a model for the patient-centered medical home for subspecialty patients.Randomized controlled trial of clopidogrel to prevent primary arteriovenous fistula failure in hemodialysis patients.A phase III, randomized, double-blind, placebo-controlled study of tenecteplase for improvement of hemodialysis catheter function: TROPICS 3Selective two-stage basilic and cephalic vein transpositions can significantly improve the rate of fistula construction.Neoangiogenesis and the presence of progenitor cells in the venous limb of an arteriovenous fistula in the ratStatin therapy is not associated with improved vascular access outcomes.Surface-Treated versus Untreated Large-Bore Catheters as Vascular Access in Hemodialysis and Apheresis Treatments.Risk factors associated with patency loss of hemodialysis vascular access within 6 monthsTiclopidine to prevent primary arteriovenous fistula failure in hemodialysis patients; a randomized controlled trial.Arteriovenous fistulas among incident hemodialysis patients in Department of Defense and Veterans Affairs facilities.K/DOQI Guidelines: What Should an Interventionalist Know?Effect of dipyridamole plus aspirin on hemodialysis graft patencyType of arteriovenous vascular access and association with patency and mortality.Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) StudyUse of aspirin associates with longer primary patency of hemodialysis grafts.In vivo nanoparticle assessment of pathological endothelium predicts the development of inflow stenosis in murine arteriovenous fistula.Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturationComparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controProvider visit frequency and vascular access interventions in hemodialysis.Two-stage brachial-basilic transposition fistula provides superior patency rates for dialysis access in a safety-net populationThe effect of in-plane arterial curvature on blood flow and oxygen transport in arterio-venous fistulae.Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes.Synthetic vascular hemodialysis access versus native arteriovenous fistula: a cost-utility analysisMatrix-embedded endothelial cells are protected from the uremic milieuThe Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modificationsEffects of Tongmai oral liquid in femoral ateriovenous fistula.Increased venous proinflammatory gene expression and intimal hyperplasia in an aorto-caval fistula model in the rat.[Preserving vascular asset in Ibn Sina Teaching Hospital, Rabat-Morocco: the role of the nurse].Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort studyAn Increase in Mean Platelet Volume/Platelet Count Ratio Is Associated with Vascular Access Failure in Hemodialysis PatientsOvercoming the memory barrier in tolerance induction: molecular mimicry and functional heterogeneity among pathogen-specific T-cell populations.A mathematical model of venous neointimal hyperplasia formation.
P2860
Q26801336-993E386F-A70F-4D81-B9C1-265C6EEA38F7Q26824460-960A1C25-7FA1-4CF4-A0AD-FA1E2E54DFB0Q27005674-5EEC8FE4-5229-4B5A-9CF3-A19597E74156Q27026061-7BA39035-1E33-4ACA-89ED-6143719EC124Q28397805-8F45BF38-5DE8-44F7-9DF6-12F2296DC9AAQ28483360-B63B490D-BEF0-4FFD-9563-D969A7364435Q30681951-60AE480D-C85E-4B20-90AA-FC1B73B893DBQ33591571-E7C3B0EB-E753-413B-AC73-CC523213EF33Q33711104-79D437B5-A17B-4ECA-AE2E-686456BA9999Q33762743-C5DA49C4-EC1D-4EA7-B45D-5355714E0F56Q33769956-7BCF33A7-B709-4C59-B5B9-F3A9DB3AE966Q33989358-3C71F181-A880-46AD-8657-E462B06A8712Q34052346-8BDC792F-C0C1-49A5-9F43-3B18223F2BF2Q34075472-F92BA7A9-CFD9-44F6-B877-B32548CAD6F5Q34266068-42A7C489-F387-44AC-B205-7B37478D9361Q34281347-BEB65110-7F59-49AE-9F8C-B094B57E50A2Q34385886-DCFA7E98-30EA-4373-89C2-2221C14F7FA4Q34455359-F8082D2A-BC8D-4A4C-80B6-1B277691C509Q34563114-6475B4C9-3F45-4728-9A04-AA65681E7DFFQ34607985-2246BE39-E0F1-40A2-910C-8B873D8117DCQ34655048-E6193D16-5DC6-40FD-8342-A15BD9449DF9Q34693036-EC3B6738-E81A-4373-A692-61EFFA5E7556Q34726912-638D3CF4-5849-4EC1-9380-F83C948463A0Q34735484-86B06C4D-001F-4F59-9617-35DF9321E0BAQ34857850-E3117A82-2302-4B68-BAC4-FE65D3972F1EQ34895169-498D80B4-6F59-4DB0-8EF2-7C555E828E06Q35051212-9F848568-240C-4D0B-B503-740F1A774C66Q35174911-8D63C3B1-8956-4144-A7A4-D919FEF4DDACQ35202776-62CFE75B-3F38-44CC-9324-5661CA014C9CQ35321704-993C50AF-FD42-4D0B-A0A5-CEC089ECCD96Q35627010-01926DBB-276A-48C8-B4F3-82376FB732CDQ35661942-0B89AEF9-D62C-4ADD-A6C0-09E44DD9FBFBQ35676161-21371753-9605-44B1-B505-DE31CF1ECE9CQ35766382-4AA90B98-59B8-4C04-A7AD-33215458AD2BQ35791476-4CB042D0-1BEF-427A-B554-52E02F810A17Q35932457-F90CFEED-CAE7-41F6-B85E-DBFAEB2ECB78Q36070270-0528D08B-5A40-4631-B9B9-EC74084F9447Q36251386-12E24313-83F7-4A2A-8EB5-4128AEEC202DQ36273291-1C29FD12-E42F-4009-85B5-99D3519D25A2Q36489278-ECB90B3E-D52D-4F00-92A4-4B2E471D5606
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Hemodialysis vascular access morbidity.
@en
Hemodialysis vascular access morbidity.
@nl
type
label
Hemodialysis vascular access morbidity.
@en
Hemodialysis vascular access morbidity.
@nl
prefLabel
Hemodialysis vascular access morbidity.
@en
Hemodialysis vascular access morbidity.
@nl
P2093
P1476
Hemodialysis vascular access morbidity.
@en
P2093
Feldman HI
Wasserstein A
P304
P577
1996-04-01T00:00:00Z